SCHEMBL8763543

SCHEMBL8763543

CCNC(=O)N(CC)C1CCCCC1.O=C=NC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.36
NPC1 O15118 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.36
RAB9A P51151 1/20 0.36
EPHX1 P07099 2/20 0.35
CCR5 P51681 1/20 0.33
HIF1A Q16665 1/20 0.33
F2 P00734 1/20 0.33
HSD11B1 P28845 1/20 0.33
TSHR P16473 1/20 0.33
PYGL P06737 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL966598 0.85 L3MBTL1 (0.45) ALDH1A1L3MBTL1NPC1KDM4EMEN1
SCHEMBL966645 0.84 L3MBTL1 (0.43) ALDH1A1L3MBTL1NPC1KDM4EMEN1
SCHEMBL966413 0.82 L3MBTL1 (0.41) ALDH1A1L3MBTL1NPC1KDM4EMEN1
SCHEMBL965813 0.77 CCR5 (0.39) ALDH1A1L3MBTL1NPC1KDM4EMEN1
SCHEMBL13911238 0.73 ADH1A (0.43) ALDH1A1L3MBTL1NPC1KDM4EMEN1
SCHEMBL968899 0.71 L3MBTL1 (0.46) ALDH1A1L3MBTL1NPC1KDM4EMEN1
SCHEMBL13900746 0.71 EPHX1 (0.40) L3MBTL1NPC1MEN1KMT2ALMNA
SCHEMBL9547591 0.71 NAAA (0.47) ALDH1A1MEN1KMT2AEPHX1
SCHEMBL27689547 0.70 SLC6A4 (0.39) KMT2AEPHX1CCR5
SCHEMBL6467642 0.70 L3MBTL1 (0.43) ALDH1A1L3MBTL1NPC1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0781272-A1 NOVEL SYNTHESIS OF PENTA-SUBSTITUTED GUANIDINES MONSANTO COMPANY (US) 1997-07-02 EP disclosed
WO-1996008469-A1 NOVEL SYNTHESIS OF PENTA-SUBSTITUTED GUANIDINES MONSANTO COMPANY (US) 1996-03-21 WO disclosed